Data has shown that patients with treatment-resistant anxiety, depression, and post-traumatic stress disorder (PTSD) could benefit from an expanded therapeutic regimen that includes psychedelic medicines. At the same time, a new survey in the United States shows that 65% of Americans are open and interested in exploring psychedelics to treat these conditions. Dr. Tiago Reis Marques explains how treatment-resistant mental health issues are currently defined, how psychedelic medicines work differently than other treatments on the market, and why there has been increased attention on psychedelic medicine of late. #
Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions
